Abdominal Obesity and the Endocannabinoid System
eBook - ePub

Abdominal Obesity and the Endocannabinoid System

From Basic Aspects to Clinical Management of Related Cardiometabolic Risk

  1. 264 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Abdominal Obesity and the Endocannabinoid System

From Basic Aspects to Clinical Management of Related Cardiometabolic Risk

About this book

This internationally renowned author team provides a unique and thorough analysis and distillation of the endocannabinoid system and its relationship to abdominal obesity, diabetes, and cardiovascular disease. The endocannabinoid system (ECS) plays an important role in cardiometabolic risk, as well as modulating energy balance, feeding behavior, he

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weā€™ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere ā€” even offline. Perfect for commutes or when youā€™re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Abdominal Obesity and the Endocannabinoid System by Jean-Pierre Despres,Vincenzo Di Marzo in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2008
eBook ISBN
9781040208601
Topic
Medicine
Subtopic
Cardiology

Table of contents

  1. Cover
  2. Half Title
  3. Title Page
  4. Copyright Page
  5. Foreword
  6. Preface
  7. Table of Contents
  8. Contributors
  9. 1 Abdominal Obesity, Metabolie Syndrome, and Risk of Cardiovascular Disease
  10. 2 Abdominal Obesity in Type 2 Diabetes
  11. 3 Obesity and Hypertension
  12. 4 Visceral Adiposity, Liver Fat, and Atherogenic Dyslipidemia
  13. 5 Visceral Adiposity and Inflammation
  14. 6 Abdominal Obesity and Alterations in Haemostasisā€”Thrombosis
  15. 7 Physiological and Metabolic Characteristics of Visceral Adipocytes
  16. 8 the Endocrine Function of Adipose Tissue: Implications of Visceral Obesity for Patients With Cardiometabolic Risk
  17. 9 Free Fatty Acid Metabolism in Visceral Obesity
  18. 10 Animal Models of Visceral Obesity
  19. 11 Insulin Sensitivity and Visceral Adiposity: Effects of Rimonabant
  20. 12 Physical Activity in the Management of Visceral Obesity and Related Cardiometabolic Risk
  21. 13 Can We Change the Lifestyle of High-Risk Patients? Lessons From the Prevention of Diabetes Trials
  22. 14 Can We Change the Body Fat Distribution Phenotype? Lessons From PparĪ³ Agonists
  23. 15 is There an Optimal Diet for the Management of Abdominal Obesity and Related Cardiometabolic Risk
  24. 16 the Ec System and Central Control of Energy Balanceā€”The Hypothalamus
  25. 17 the Ec System and Central Control of Energy Balance: the Nucleus Accumbens
  26. 18 the Ec System and the HPA Axis
  27. 19 the Ec System and Gutā€“Brain Interactions Relevant to Satiety
  28. 20 the Endogenous Cannabinoid System in the Gastrointestinal Tract
  29. 21 the Ec System in the Adipose Tissue and Endocrine Pancreas
  30. 22 the Ec System in the Immune System and the Inflammatory Response
  31. 23 the Endocannabinoid System in the Liver
  32. 24 the Endocannabinoid System and Cardiovascular Disease
  33. 25 the Endocannabinoid System, Energy Expenditure, and Thermogenesis
  34. 26 Effects of Dietary Fatty Acids on Endocannabinoid Signaling in the Brain and Peripheral Organs
  35. 27 Endocannabinoid Overactivity and Abdominal Obesity
  36. 28 Cb1Antagonism in the Management of Abdominal Obesity
  37. 29 Abdominal Obesity and the Endocannabinoid System 0Ī’ĪŠ Blockade, Insulin Resistance, and Type 2 Diabetes
  38. 30 Abdominal Obesity as a Therapeutic Target to Manage the Atherogenic Dyslipidemia and Related Metabolic Abnormalities
  39. 31 Cb1Blockade and Hypertension
  40. 32 Future Developments 1: Cb1 Blockade for Weight Gain Subsequent to Smoking Cessation
  41. 33 Future Developments 2: Cannabinoid Cb1Receptor Blockade in Weight Gain Subsequent to Psychiatric Disorder Treatment
  42. Index